Skip to main content
Erschienen in: Tumor Biology 4/2016

24.10.2015 | Original Article

Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1

verfasst von: Kewei Zhu, Wanchun Wang

Erschienen in: Tumor Biology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

(−)-Epigallocatechin-3-gallate (EGCG), the most abundant and active polyphenol in green tea, has been demonstrated to have anticancer effects in a wide variety of human cancer. MicroRNAs (miRNAs) are a class of short noncoding RNAs and play important role in gene regulation and are critically involved in the pathogenesis and progression of human cancer. This study aims to investigate the effects of EGCG on osteosarcoma (OS) cells and elucidate the underlying mechanism. Cellular function assays revealed that EGCG inhibited cell proliferation, induced cell cycle arrest and promoted apoptosis of OS cells in vitro, and also inhibited the growth of transplanted tumors in vivo. By miRNA microarray and RT-qPCR analysis, miR-1 was found to be significantly upregulated in MG-63 and U-2OS treated by EGCG in dose- and time-dependent manners, and miR-1 downregulation by inhibitor mimics attenuated EGCG-induced inhibition on cell growth of OS cells. We also confirmed that miR-1 was also frequently decreased in clinical OS tumor tissues. Moreover, both EGCG and miR-1 mimic inhibited c-MET expression, and combination treatment with EGCG and c-MET inhibitor (crizotinib) had enhanced inhibitory effects on the growth of MG-63 and U-2OS cells. Taken together, these results suggest that EGCG has an anticancer effect on OS cells, at least partially, through regulating miR-1/c-MET interaction.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment—where do we stand? A state of the art review. Cancer Treat Rev. 2014;40:523–32.CrossRefPubMed Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment—where do we stand? A state of the art review. Cancer Treat Rev. 2014;40:523–32.CrossRefPubMed
2.
Zurück zum Zitat He H, Ni J, Huang J. Molecular mechanisms of chemoresistance in osteosarcoma (review). Oncol Lett. 2014;7:1352–62.PubMedPubMedCentral He H, Ni J, Huang J. Molecular mechanisms of chemoresistance in osteosarcoma (review). Oncol Lett. 2014;7:1352–62.PubMedPubMedCentral
3.
Zurück zum Zitat Chen D, Wan SB, Yang H, Yuan J, Chan TH, Dou QP. Egcg, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem. 2011;53:155–77.CrossRefPubMedPubMedCentral Chen D, Wan SB, Yang H, Yuan J, Chan TH, Dou QP. Egcg, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem. 2011;53:155–77.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Lamoral-Theys D, Pottier L, Dufrasne F, Neve J, Dubois J, Kornienko A, et al. Natural polyphenols that display anticancer properties through inhibition of kinase activity. Curr Med Chem. 2010;17:812–25.CrossRefPubMed Lamoral-Theys D, Pottier L, Dufrasne F, Neve J, Dubois J, Kornienko A, et al. Natural polyphenols that display anticancer properties through inhibition of kinase activity. Curr Med Chem. 2010;17:812–25.CrossRefPubMed
5.
Zurück zum Zitat Garg AK, Buchholz TA, Aggarwal BB. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal. 2005;7:1630–47.CrossRefPubMed Garg AK, Buchholz TA, Aggarwal BB. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal. 2005;7:1630–47.CrossRefPubMed
6.
Zurück zum Zitat Fujiki H, Suganuma M, Kurusu M, Okabe S, Imayoshi Y, Taniguchi S, et al. New tnf-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with egcg and sulindac or tamoxifen. Mutat Res. 2003;523–524:119–25.CrossRefPubMed Fujiki H, Suganuma M, Kurusu M, Okabe S, Imayoshi Y, Taniguchi S, et al. New tnf-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with egcg and sulindac or tamoxifen. Mutat Res. 2003;523–524:119–25.CrossRefPubMed
7.
Zurück zum Zitat Suganuma M, Saha A, Fujiki H. New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci. 2011;102:317–23.CrossRefPubMed Suganuma M, Saha A, Fujiki H. New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci. 2011;102:317–23.CrossRefPubMed
9.
Zurück zum Zitat Farazi TA, Spitzer JI, Morozov P, Tuschl T. Mirnas in human cancer. J Pathol. 2011;223:102–15.CrossRefPubMed Farazi TA, Spitzer JI, Morozov P, Tuschl T. Mirnas in human cancer. J Pathol. 2011;223:102–15.CrossRefPubMed
10.
Zurück zum Zitat Milenkovic D, Jude B, Morand C. Mirna as molecular target of polyphenols underlying their biological effects. Free Radic Biol Med. 2013;64:40–51.CrossRefPubMed Milenkovic D, Jude B, Morand C. Mirna as molecular target of polyphenols underlying their biological effects. Free Radic Biol Med. 2013;64:40–51.CrossRefPubMed
11.
12.
Zurück zum Zitat Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S, et al. Targeting mirnas involved in cancer stem cell and emt regulation: an emerging concept in overcoming drug resistance. Drug Resist Updat Rev Commentaries Antimicrob Anticancer Chemother. 2010;13:109–18. Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S, et al. Targeting mirnas involved in cancer stem cell and emt regulation: an emerging concept in overcoming drug resistance. Drug Resist Updat Rev Commentaries Antimicrob Anticancer Chemother. 2010;13:109–18.
13.
Zurück zum Zitat Zhang J, Chen YL, Ji G, Fang W, Gao Z, Liu Y, et al. Sorafenib inhibits epithelial-mesenchymal transition through an epigenetic-based mechanism in human lung epithelial cells. PLoS One. 2013;8, e64954.CrossRefPubMedPubMedCentral Zhang J, Chen YL, Ji G, Fang W, Gao Z, Liu Y, et al. Sorafenib inhibits epithelial-mesenchymal transition through an epigenetic-based mechanism in human lung epithelial cells. PLoS One. 2013;8, e64954.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Schramm L. Going green: the role of the green tea component egcg in chemoprevention. J Carcinogenesis Mutagen. 2013;4:1000142.CrossRef Schramm L. Going green: the role of the green tea component egcg in chemoprevention. J Carcinogenesis Mutagen. 2013;4:1000142.CrossRef
15.
Zurück zum Zitat Park JS, Khoi PN, Joo YE, Lee YH, Lang SA, Stoeltzing O, et al. Egcg inhibits recepteur d’origine nantais expression by suppressing egr-1 in gastric cancer cells. Int J Oncol. 2013;42:1120–6.PubMed Park JS, Khoi PN, Joo YE, Lee YH, Lang SA, Stoeltzing O, et al. Egcg inhibits recepteur d’origine nantais expression by suppressing egr-1 in gastric cancer cells. Int J Oncol. 2013;42:1120–6.PubMed
16.
Zurück zum Zitat Ogawa K, Hara T, Shimizu M, Nagano J, Ohno T, Hoshi M, et al. (−)-epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells. Oncol Lett. 2012;4:546–50.PubMedPubMedCentral Ogawa K, Hara T, Shimizu M, Nagano J, Ohno T, Hoshi M, et al. (−)-epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells. Oncol Lett. 2012;4:546–50.PubMedPubMedCentral
17.
Zurück zum Zitat Ma YC, Li C, Gao F, Xu Y, Jiang ZB, Liu JX, et al. Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the egfr signaling pathway. Oncol Rep. 2014;31:1343–9.PubMed Ma YC, Li C, Gao F, Xu Y, Jiang ZB, Liu JX, et al. Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the egfr signaling pathway. Oncol Rep. 2014;31:1343–9.PubMed
18.
Zurück zum Zitat Braicu C, Gherman CD, Irimie A, Berindan-Neagoe I. Epigallocatechin-3-gallate (egcg) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells. J Nanosci Nanotechnol. 2013;13:632–7.CrossRefPubMed Braicu C, Gherman CD, Irimie A, Berindan-Neagoe I. Epigallocatechin-3-gallate (egcg) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells. J Nanosci Nanotechnol. 2013;13:632–7.CrossRefPubMed
19.
Zurück zum Zitat Trudel D, Labbe DP, Araya-Farias M, Doyen A, Bazinet L, Duchesne T, et al. A two-stage, single-arm, phase ii study of egcg-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer. Gynecol Oncol. 2013;131:357–61.CrossRefPubMed Trudel D, Labbe DP, Araya-Farias M, Doyen A, Bazinet L, Duchesne T, et al. A two-stage, single-arm, phase ii study of egcg-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer. Gynecol Oncol. 2013;131:357–61.CrossRefPubMed
20.
Zurück zum Zitat Hsieh TC, Wu JM. Targeting cwr22rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals egcg, genistein and quercetin. Anticancer Res. 2009;29:4025–32.PubMedPubMedCentral Hsieh TC, Wu JM. Targeting cwr22rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals egcg, genistein and quercetin. Anticancer Res. 2009;29:4025–32.PubMedPubMedCentral
21.
Zurück zum Zitat Hwang JT, Ha J, Park IJ, Lee SK, Baik HW, Kim YM, et al. Apoptotic effect of egcg in ht-29 colon cancer cells via ampk signal pathway. Cancer Lett. 2007;247:115–21.CrossRefPubMed Hwang JT, Ha J, Park IJ, Lee SK, Baik HW, Kim YM, et al. Apoptotic effect of egcg in ht-29 colon cancer cells via ampk signal pathway. Cancer Lett. 2007;247:115–21.CrossRefPubMed
22.
Zurück zum Zitat Park IJ, Lee YK, Hwang JT, Kwon DY, Ha J, Park OJ. Green tea catechin controls apoptosis in colon cancer cells by attenuation of h2o2-stimulated cox-2 expression via the ampk signaling pathway at low-dose h2o2. Ann N Y Acad Sci. 2009;1171:538–44.CrossRefPubMed Park IJ, Lee YK, Hwang JT, Kwon DY, Ha J, Park OJ. Green tea catechin controls apoptosis in colon cancer cells by attenuation of h2o2-stimulated cox-2 expression via the ampk signaling pathway at low-dose h2o2. Ann N Y Acad Sci. 2009;1171:538–44.CrossRefPubMed
23.
Zurück zum Zitat Xu L, Zhang Y, Wang H, Zhang G, Ding Y, Zhao L. Tumor suppressor mir-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the mapk and pi3k/akt pathway. J Transl Med. 2014;12:244.CrossRefPubMedPubMedCentral Xu L, Zhang Y, Wang H, Zhang G, Ding Y, Zhao L. Tumor suppressor mir-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the mapk and pi3k/akt pathway. J Transl Med. 2014;12:244.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Kawakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Kagara I, et al. The functional significance of mir-1 and mir-133a in renal cell carcinoma. Eur J Cancer. 2012;48:827–36.CrossRefPubMed Kawakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Kagara I, et al. The functional significance of mir-1 and mir-133a in renal cell carcinoma. Eur J Cancer. 2012;48:827–36.CrossRefPubMed
25.
Zurück zum Zitat Li D, Yang P, Li H, Cheng P, Zhang L, Wei D, et al. Microrna-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1. Life Sci. 2012;91:440–7.CrossRefPubMed Li D, Yang P, Li H, Cheng P, Zhang L, Wei D, et al. Microrna-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1. Life Sci. 2012;91:440–7.CrossRefPubMed
26.
Zurück zum Zitat Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, et al. The tumour-suppressive function of mir-1 and mir-133a targeting tagln2 in bladder cancer. Br J Cancer. 2011;104:808–18.CrossRefPubMedPubMedCentral Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, et al. The tumour-suppressive function of mir-1 and mir-133a targeting tagln2 in bladder cancer. Br J Cancer. 2011;104:808–18.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Hudson RS, Yi M, Esposito D, Watkins SK, Hurwitz AA, Yfantis HG, et al. Microrna-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res. 2012;40:3689–703.CrossRefPubMed Hudson RS, Yi M, Esposito D, Watkins SK, Hurwitz AA, Yfantis HG, et al. Microrna-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res. 2012;40:3689–703.CrossRefPubMed
28.
Zurück zum Zitat Novello C, Pazzaglia L, Cingolani C, Conti A, Quattrini I, Manara MC, et al. Mirna expression profile in human osteosarcoma: role of mir-1 and mir-133b in proliferation and cell cycle control. Int J Oncol. 2013;42:667–75.PubMed Novello C, Pazzaglia L, Cingolani C, Conti A, Quattrini I, Manara MC, et al. Mirna expression profile in human osteosarcoma: role of mir-1 and mir-133b in proliferation and cell cycle control. Int J Oncol. 2013;42:667–75.PubMed
29.
Zurück zum Zitat Sampson ER, Martin BA, Morris AE, Xie C, Schwarz EM, O’Keefe RJ, et al. The orally bioavailable met inhibitor pf-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model. J Bone Miner Res Off J Am Soc Bone Miner Res. 2011;26:1283–94.CrossRef Sampson ER, Martin BA, Morris AE, Xie C, Schwarz EM, O’Keefe RJ, et al. The orally bioavailable met inhibitor pf-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model. J Bone Miner Res Off J Am Soc Bone Miner Res. 2011;26:1283–94.CrossRef
30.
Zurück zum Zitat Migliore C, Martin V, Leoni VP, Restivo A, Atzori L, Petrelli A, et al. Mir-1 downregulation cooperates with macc1 in promoting met overexpression in human colon cancer. Clinical Cancer Res Off J Am Assoc Cancer Res. 2012;18:737–47.CrossRef Migliore C, Martin V, Leoni VP, Restivo A, Atzori L, Petrelli A, et al. Mir-1 downregulation cooperates with macc1 in promoting met overexpression in human colon cancer. Clinical Cancer Res Off J Am Assoc Cancer Res. 2012;18:737–47.CrossRef
31.
Zurück zum Zitat Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, et al. Down-regulation of micro-rna-1 (mir-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by mir-1. J Biol Chem. 2008;283:33394–405.CrossRefPubMedPubMedCentral Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, et al. Down-regulation of micro-rna-1 (mir-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by mir-1. J Biol Chem. 2008;283:33394–405.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Yan D, Dong Xda E, Chen X, Wang L, Lu C, Wang J, et al. Microrna-1/206 targets c-met and inhibits rhabdomyosarcoma development. J Biol Chem. 2009;284:29596–604.CrossRefPubMedPubMedCentral Yan D, Dong Xda E, Chen X, Wang L, Lu C, Wang J, et al. Microrna-1/206 targets c-met and inhibits rhabdomyosarcoma development. J Biol Chem. 2009;284:29596–604.CrossRefPubMedPubMedCentral
Metadaten
Titel
Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1
verfasst von
Kewei Zhu
Wanchun Wang
Publikationsdatum
24.10.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 4/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4187-3

Weitere Artikel der Ausgabe 4/2016

Tumor Biology 4/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.